Christoffer Clemmensen

This study identifies chondroitin sulfate as a potential therapeutic target for type 2 diabetes through genetic and preclinical evidence showing its effects on glycemic control and insulin action.

This study shows dietary medium-chain fatty acids provide metabolic benefits without requiring hepatic ketogenesis.

This paper identifies a hypothalamus-brainstem circuit that prioritizes safety over essential needs by modulating locomotion behavior.

This study examines sex-specific metabolic effects of FGF21 deficiency and glucagon analog treatment in female mice, revealing exacerbated obesity and altered glucose tolerance in females.

This study shows overfeeding in mice does not increase energy expenditure or excretion, and weight gain is mainly countered by reduced food intake.